Harris AL - Search Results

1

Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs.

Arnaiz E, Miar A, Bridges E, Prasad N, Hatch SB, Ebner D, Lawrie CH, Harris AL. Arnaiz E, et al. Among authors: harris al. BMC Cancer. 2021 Aug 5;21(1):896. doi: 10.1186/s12885-021-08616-8. BMC Cancer. 2021. PMID: 34353313 Free PMC article.

2

Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines.

Houlbrook S, Addison CM, Davies SL, Carmichael J, Stratford IJ, Harris AL, Hickson ID. Houlbrook S, et al. Among authors: harris al. Br J Cancer. 1995 Dec;72(6):1454-61. doi: 10.1038/bjc.1995.529. Br J Cancer. 1995. PMID: 8519659 Free PMC article.

3

Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines.

Blancher C, Moore JW, Talks KL, Houlbrook S, Harris AL. Blancher C, et al. Among authors: harris al. Cancer Res. 2000 Dec 15;60(24):7106-13. Cancer Res. 2000. PMID: 11156418

4

Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.

Blancher C, Moore JW, Robertson N, Harris AL. Blancher C, et al. Among authors: harris al. Cancer Res. 2001 Oct 1;61(19):7349-55. Cancer Res. 2001. PMID: 11585776

5

A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines.

Chong TW, Horwitz LD, Moore JW, Sowter HM, Harris AL. Chong TW, et al. Among authors: harris al. Cancer Res. 2002 Dec 1;62(23):6924-7. Cancer Res. 2002. PMID: 12460908

6

Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia.

Sowter HM, Raval RR, Moore JW, Ratcliffe PJ, Harris AL. Sowter HM, et al. Among authors: harris al. Cancer Res. 2003 Oct 1;63(19):6130-4. Cancer Res. 2003. PMID: 14559790

7

Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene.

Wykoff CC, Sotiriou C, Cockman ME, Ratcliffe PJ, Maxwell P, Liu E, Harris AL. Wykoff CC, et al. Among authors: harris al. Br J Cancer. 2004 Mar 22;90(6):1235-43. doi: 10.1038/sj.bjc.6601657. Br J Cancer. 2004. PMID: 15026807 Free PMC article.

8

The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers.

Chakrabarti J, Turley H, Campo L, Han C, Harris AL, Gatter KC, Fox SB. Chakrabarti J, et al. Among authors: harris al. Br J Cancer. 2004 Aug 31;91(5):954-8. doi: 10.1038/sj.bjc.6602059. Br J Cancer. 2004. PMID: 15328513 Free PMC article.

9

Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate.

Jones DT, Trowbridge IS, Harris AL. Jones DT, et al. Among authors: harris al. Cancer Res. 2006 Mar 1;66(5):2749-56. doi: 10.1158/0008-5472.CAN-05-3857. Cancer Res. 2006. PMID: 16510596

10

The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.

Winter SC, Shah KA, Han C, Campo L, Turley H, Leek R, Corbridge RJ, Cox GJ, Harris AL. Winter SC, et al. Among authors: harris al. Cancer. 2006 Aug 15;107(4):757-66. doi: 10.1002/cncr.21983. Cancer. 2006. PMID: 16826581 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,286 results

Search Page

Filters